Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples